FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF GABAPENTIN

In the present study, an attempt has been made to develop controlled release tablets of Galantine by selecting different types of polymers Eudragit S 100, Ethyl Cellulose and Hydroponically Cellulose as retarding polymers. All the formulations were prepared by direct compression method. The blend of all the formulations showed good flow properties such as angle of repose, bulk density, tapped density. The prepared tablets were shown good post compression parameters and they passed all the quality control evaluation parameters as per I.P limits. Among all the formulations F8 formulation showed maximum % drug release i.e., 98.94 % in 12 hours. Hence it is considered as optimized formulation F8 which contains Hydroponically Cellulose (100 mg). Whereas the formulations with Eudragit S 100 showed more retarding with low concentration of polymer. The formulations with Ethyl Cellulose were unable to produce the desired drug release pattern. The results of the accelerated stability study of final formulation for 3 month revealed that storage conditions were not found to have made any significant changes infinal formulation.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-15
DOI
https://doi.org/10.5281/zenodo.17615116
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF GABAPENTIN

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF GABAPENTIN

article en

Abstract

In the present study, an attempt has been made to develop controlled release tablets of Galantine by selecting different types of polymers Eudragit S 100, Ethyl Cellulose and Hydroponically Cellulose as retarding polymers. All the formulations were prepared by direct compression method. The blend of all the formulations showed good flow properties such as angle of repose, bulk density, tapped density. The prepared tablets were shown good post compression parameters and they passed all the quality control evaluation parameters as per I.P limits. Among all the formulations F8 formulation showed maximum % drug release i.e., 98.94 % in 12 hours. Hence it is considered as optimized formulation F8 which contains Hydroponically Cellulose (100 mg). Whereas the formulations with Eudragit S 100 showed more retarding with low concentration of polymer. The formulations with Ethyl Cellulose were unable to produce the desired drug release pattern. The results of the accelerated stability study of final formulation for 3 month revealed that storage conditions were not found to have made any significant changes infinal formulation.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 48%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.